Gyre Therapeutics, Inc.
GYRE
$8.71
-$0.10-1.14%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.29% | -0.03% | -32.80% | 11.47% | 51.17% |
| Total Receivables | 40.33% | 4.34% | 18.90% | -0.56% | -- |
| Inventory | -0.66% | 13.20% | 14.09% | 15.37% | -- |
| Prepaid Expenses | 13.13% | -8.85% | -35.59% | 15.71% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -5.09% | -12.14% | -9.23% | 81.53% | -- |
| Total Current Assets | 18.20% | 2.41% | -14.67% | 9.62% | -- |
|
|
|||||
| Total Current Assets | 18.20% | 2.41% | -14.67% | 9.62% | -- |
| Net Property, Plant & Equipment | -2.75% | 2.55% | 7.72% | 0.61% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.53% | 0.79% | -1.55% | -1.30% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -32.57% | 14.61% | 5.76% | 1.63% | -- |
| Total Assets | 0.13% | 3.56% | -0.89% | 4.69% | -- |
|
|
|||||
| Total Accounts Payable | -64.36% | 11.81% | -17.88% | -7.04% | -- |
| Total Accrued Expenses | 13.95% | -10.48% | -6.29% | -7.85% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.74% | 5.31% | 559.00% | -52.38% | -- |
| Total Finance Division Other Current Liabilities | 69.05% | 0.56% | -40.75% | 4.52% | -- |
| Total Other Current Liabilities | 69.05% | 0.56% | -40.75% | 4.52% | -- |
| Total Current Liabilities | 32.62% | -5.51% | -20.08% | -2.80% | -- |
|
|
|||||
| Total Current Liabilities | 32.62% | -5.51% | -20.08% | -2.80% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -19.62% | -15.11% | 641.14% | -12.06% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -39.69% | 2.21% | -21.11% | -23.80% | -- |
| Total Liabilities | 0.89% | -2.96% | -17.02% | -12.68% | -- |
|
|
|||||
| Common Stock & APIC | 1.41% | 0.48% | 0.34% | 95.27% | -- |
| Retained Earnings | -0.14% | 1.57% | 4.71% | 9.14% | -- |
| Treasury Stock & Other | -174.52% | 52.94% | -15.78% | -5.60% | -- |
| Total Common Equity | 0.22% | 4.69% | 6.55% | 457.85% | -116.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.22% | 4.69% | 6.55% | 457.85% | -116.22% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -0.60% | 6.97% | 2.69% | 7.91% | -- |
| Total Equity | -0.07% | 5.49% | 5.15% | 13.12% | -19.59% |
|
|
|||||